![Health / MannKind Corporation / Insulin therapy / Inhalable insulin / Diabetes management / Diabetes mellitus / Insulin / Sanofi / Blood glucose monitoring / Diabetes / Medicine / Endocrine system Health / MannKind Corporation / Insulin therapy / Inhalable insulin / Diabetes management / Diabetes mellitus / Insulin / Sanofi / Blood glucose monitoring / Diabetes / Medicine / Endocrine system](https://www.pdfsearch.io/img/1b5d1301d31bffd32b48b1a823ccfbc2.jpg) Date: 2014-10-09 14:57:02Health MannKind Corporation Insulin therapy Inhalable insulin Diabetes management Diabetes mellitus Insulin Sanofi Blood glucose monitoring Diabetes Medicine Endocrine system | | PRESS RELEASE Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin Paris and Valencia, Calif. - August 11, [removed]Sanofi (EURONEXT: SAN and NYSE: SNY) and MaAdd to Reading ListSource URL: en.sanofi.comDownload Document from Source Website File Size: 81,44 KBShare Document on Facebook
|